| Dr Samantha Fay Ghiselli, MD | |
|
501 S Cherry St Ste 310, Glendale, CO 80246-1322 | |
| (303) 333-7873 | |
| (303) 321-7873 |
| Full Name | Dr Samantha Fay Ghiselli |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 22 Years |
| Location | 501 S Cherry St Ste 310, Glendale, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942212857 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Samantha Ghiselli Md Pllc | 8820485261 | 2 |
News Archive
Researchers from Weill Cornell Medical College and Columbia University College of Physicians & Surgeons have discovered at least one way in which beta-amyloid, the protein that forms stubborn plaques in the brains of Alzheimer's disease patients, can kill nerve cells.
A new study published in the Journal for Healthcare Quality revealed that nursing resources vary significantly across different types of hospitals that care for children, and this has significant implications for quality and safety in pediatric medical care.
Researchers at Harvard Medical School, Massachusetts Institute of Technology and Northwestern University have identified a subtype of autism arising from a cluster of genes that regulate cholesterol metabolism and brain development.
A Northwestern University-led study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments.
Flexuspine, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted conditional approval to begin the initial phase of the Investigational Device Exemption (IDE) for a feasibility study of its FSU device. This is the first approved clinical study for a Total Spine Arthroplasty system in the U.S.
› Verified 5 days ago
| Entity Name | Denver Dermatology Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477564524 PECOS PAC ID: 9537058466 Enrollment ID: O20040310001473 |
News Archive
Researchers from Weill Cornell Medical College and Columbia University College of Physicians & Surgeons have discovered at least one way in which beta-amyloid, the protein that forms stubborn plaques in the brains of Alzheimer's disease patients, can kill nerve cells.
A new study published in the Journal for Healthcare Quality revealed that nursing resources vary significantly across different types of hospitals that care for children, and this has significant implications for quality and safety in pediatric medical care.
Researchers at Harvard Medical School, Massachusetts Institute of Technology and Northwestern University have identified a subtype of autism arising from a cluster of genes that regulate cholesterol metabolism and brain development.
A Northwestern University-led study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments.
Flexuspine, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted conditional approval to begin the initial phase of the Investigational Device Exemption (IDE) for a feasibility study of its FSU device. This is the first approved clinical study for a Total Spine Arthroplasty system in the U.S.
› Verified 5 days ago
| Entity Name | Pure Dermatology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407363971 PECOS PAC ID: 8325384175 Enrollment ID: O20190115002747 |
News Archive
Researchers from Weill Cornell Medical College and Columbia University College of Physicians & Surgeons have discovered at least one way in which beta-amyloid, the protein that forms stubborn plaques in the brains of Alzheimer's disease patients, can kill nerve cells.
A new study published in the Journal for Healthcare Quality revealed that nursing resources vary significantly across different types of hospitals that care for children, and this has significant implications for quality and safety in pediatric medical care.
Researchers at Harvard Medical School, Massachusetts Institute of Technology and Northwestern University have identified a subtype of autism arising from a cluster of genes that regulate cholesterol metabolism and brain development.
A Northwestern University-led study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments.
Flexuspine, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted conditional approval to begin the initial phase of the Investigational Device Exemption (IDE) for a feasibility study of its FSU device. This is the first approved clinical study for a Total Spine Arthroplasty system in the U.S.
› Verified 5 days ago
| Entity Name | Samantha Ghiselli Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689253734 PECOS PAC ID: 8820485261 Enrollment ID: O20220503001896 |
News Archive
Researchers from Weill Cornell Medical College and Columbia University College of Physicians & Surgeons have discovered at least one way in which beta-amyloid, the protein that forms stubborn plaques in the brains of Alzheimer's disease patients, can kill nerve cells.
A new study published in the Journal for Healthcare Quality revealed that nursing resources vary significantly across different types of hospitals that care for children, and this has significant implications for quality and safety in pediatric medical care.
Researchers at Harvard Medical School, Massachusetts Institute of Technology and Northwestern University have identified a subtype of autism arising from a cluster of genes that regulate cholesterol metabolism and brain development.
A Northwestern University-led study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments.
Flexuspine, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted conditional approval to begin the initial phase of the Investigational Device Exemption (IDE) for a feasibility study of its FSU device. This is the first approved clinical study for a Total Spine Arthroplasty system in the U.S.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samantha Fay Ghiselli, MD 501 S Cherry St Ste 310, Glendale, CO 80246-1322 Ph: (303) 333-7873 | Dr Samantha Fay Ghiselli, MD 501 S Cherry St Ste 310, Glendale, CO 80246-1322 Ph: (303) 333-7873 |
News Archive
Researchers from Weill Cornell Medical College and Columbia University College of Physicians & Surgeons have discovered at least one way in which beta-amyloid, the protein that forms stubborn plaques in the brains of Alzheimer's disease patients, can kill nerve cells.
A new study published in the Journal for Healthcare Quality revealed that nursing resources vary significantly across different types of hospitals that care for children, and this has significant implications for quality and safety in pediatric medical care.
Researchers at Harvard Medical School, Massachusetts Institute of Technology and Northwestern University have identified a subtype of autism arising from a cluster of genes that regulate cholesterol metabolism and brain development.
A Northwestern University-led study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments.
Flexuspine, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted conditional approval to begin the initial phase of the Investigational Device Exemption (IDE) for a feasibility study of its FSU device. This is the first approved clinical study for a Total Spine Arthroplasty system in the U.S.
› Verified 5 days ago